LIVNLivaNova PLC
Electromedical & Electrotherapeutic Apparatus
- Revenue
- $1.4B
- 11% YoY
- Operating margin
- 14.4%
- 40% YoY
- EBITDA
- $228M
- 48% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -1.0×
- −$227M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear30% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B | 11% |
| Operating income | −$784K | −$77M | −$68M | $129M | $199M | 55% |
| Net income | −$136M | −$86M | $18M | $63M | −$243M | 484% |
| Operating cash flow | $103M | $70M | $75M | $183M | $254M | 39% |
| Capex | $25M | $27M | $35M | $47M | $81M | 72% |
| Stock-based comp | $41M | $45M | $36M | $34M | $36M | 7.0% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $460K · 2
- Net
- −$460K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $8M | $15M | 93 | 127 |
| FY2024 | — | — | 70 | 117 |
| FY2023 | — | — | 78 | 106 |
| FY2022 | — | — | 84 | 97 |
| FY2021 | — | — | 132 | 119 |